Jefferies Upgrades Chemed to Buy, Raises Price Target to $620

Benzinga · 4d ago
Jefferies analyst Brian Tanquilut upgrades Chemed (NYSE:CHE) from Hold to Buy and raises the price target from $520 to $620.